Home Current Issue
Current Issue
2026 Volume 57 Issue 9  Published: 2026-09-10
    Perspective & Review
  • Mengfei DONG, Tailin WANG, Jingyi ZHANG, Wenxia ZOU, Shu HAN, Xianglei LIU
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.001

    Human cytomegalovirus(HCMV) has an infection rate of over 90% in the general population. Although it mostly remains in an asymptomatic latent-infection state, it is the major pathogen responsible for congenital infection in newborns and fatal complications in immunocompromised patients. Currently, the prevention and treatment of HCMV infection face multiple challenges, including drug resistance, toxicity, and immune escape, highlighting the urgent need to integrate novel drugs and therapeutic strategies. The HCMV prevention and treatment strategies are evolving from single antiviral approaches toward multimodal synergistic directions. In the future, it will be necessary to combine structural biology, immune engineering, and clinical translational research to optimize comprehensive intervention systems. This review summarizes the research progress and future prospects of different types of drugs or strategies, including HCMV vaccines, anti-HCMV drugs, HCMV antibody drugs, and specific T-cell infusion therapy, with the aim of providing a reference for optimizing HCMV prevention and treatment strategies.

  • Perspective & Review
  • Mengni FAN, Tingting ZHANG, Guohong QIN
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.002

    The drug-to-antibody ratio(DAR) is a critical quality attribute of antibody-drug conjugates(ADCs),directly affecting their efficacy, safety, and pharmacokinetic properties. This review systematically summarizes the analytical methods for DAR determination and optimization strategies for homogeneous ADCs. Current detection technologies include hydrophobic interaction chromatography, reversed-phase high-performance liquid chromatography, mass spectrometry,ultraviolet-visible spectroscopy, and emerging multi-dimensional liquid chromatography hyphenated techniques. In terms of homogeneity optimization, engineered site-specific conjugation approaches(e.g., THIOMAB, enzymatic conjugation)enable precise control of DAR. Hydrophilic modification of linkers and optimization of payload structure help improve drug loading while maintaining antibody stability. The optimal DAR should be determined by comprehensively considering target expression levels, tumor heterogeneity, and payload properties. This review provides references for ADC process development and quality control.

  • Perspective & Review
  • Wenting OUYANG, Yanmei LI, Yuxia SUN, Shunnan ZHANG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.003

    Dry granulation is a green granulation process commonly used in the preparation of solid dosage forms of traditional Chinese medicine, and process scale-up is a critical step for realizing industrial production. Factors affecting granule quality include formulation factors, process parameters, and equipment factors. Among these, the physical properties of the material directly determine whether the material is suitable for dry granulation, while roller pressure is a critical process parameter influencing granule formation. However, current research on dry granulation process scale-up mainly relies on empirical experience and manual judgment, which can hardly meet the requirements of quality consistency in modern pharmaceutical development. According to whether the same series of equipment is used, this article summarizes two types of scale-up strategies: engineering-based similarity scale-up, and model-assisted scale-up based on process analytical technology or physics. Common problems encountered during scale-up are also analyzed in depth, and corresponding solutions are proposed, aiming to provide a reference for the scale-up of dry granulation processes.

  • Paper
  • Xingyu WU, Jiahui WANG, Misi LI, Qingwei ZHANG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.004

    This study improved the synthesis process of the histone deacetylase inhibitor givinostat(1). Starting from 2,6-naphthalenedicarboxylic acid(2), 6-[(diethylamino)carbonyl]-2-naphthalenecarboxylic acid(3) was prepared via amide condensation with diethylamine. Compound 3was reduced with sodium borohydride/boron trifluoride etherate to obtain 6-[(diethylamino)methyl]-2-naphthalenemethanol(4), which was then converted into its hydrochloride salt in a solution of hydrogen chloride in ethyl acetate. Methyl 4-aminobenzoate(5) underwent a nucleophilic addition-elimination reaction with triphosgene to form an isocyanate intermediate, which then reacted with 4hydrochloride via nucleophilic addition to afford methyl 4-[[[[6-[(diethylamino)methyl]-2-naphthyl]methoxy]carbonyl]amino]benzoate(6). Hydrolysis of 6 with lithium hydroxide monohydrate afforded 4-[[[[6-[(diethylamino)methyl]-2-naphthyl]methoxy]carbonyl]-amino]benzoic acid(7). Compound 7 was subjected to an amide condensation reaction with O-(tetrahydropyran-2-yl)-hydroxylamine(O-THP) and was then hydrolyzed using hydrochloric acid, providing the target compound 1with an overall yield of 27.2%(based on 2) and an HPLC purity of 99.31%. The improved process features simple operation, high yield,mild conditions, and high product purity.

  • Paper
  • Qingtong MA, Zhenyu LIU, Jianxing NIU, Guanghao LIU, Yangsheng CHEN
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.005

    Based on the characteristics of molecular structure and synthetic process of falecalcitriol, together with a literature review, five related substances were identified, including process impurities, degradation impurities, and potential impurities. These were (1S,3R,14S,5Z,7E,23E)-26,26,26,27,27,27-hexafluoro-9,10-secocholesta-5,7,10(19),23-tetraene-1,3,25-triol(F2), (1S,3R,14S,5E,7E)-26,26,26,27,27,27-hexafluoro-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol(F3), (1S,3R,14S,5E,6Z,8Z)-26,26,26,27,27,27-hexafluoro-9,10-secocholesta-5(10),6,8(9)-triene-1,3,25-triol(F4), (1S,3R,14S,20S,5Z,7E)-26,26,26,27,27,27-hexafluoro-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol(F5),and (1S,3R,14S,5Z,7E)-26,26,26,27,27,27-hexafluoro-9,10-secocholesta-5,7,10(19),24-tetraene-1,3-diol(F6). By systematically analyzing the formation pathways and actual detected levels of these related substances, corresponding control strategies were established. Furthermore, related substances F2, F4, F5 and F6 were synthesized in this study,providing essential references for analytical method development and quality standard formulation.

  • Paper
  • Zhenping SHAO, Lingzhi LEI, Jing ZHANG, Jianguo YANG, Youfu WANG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.006

    To support the quality control of budesonide, related substances B, C, J, and L specified in EP 11.0 were synthesized, namely 16α,17-[(1RS)-ethylidenebis(oxy)]-11β,21-dihydroxy-pregna-1,4-diene-3,20-dione(related substance B), 16α,17-[(1RS)-butylidenebis(oxy)]-11β-hydroxy-17-(hydroxymethyl)-D-homoandrosta-1,4-diene-3,17a-dione(related substance C), 16α,17-[(1RS)-butylidenebis(oxy)]-9α-bromo-11β,21-dihydroxy-pregna-1,4-diene-3,20-dione(related substance J) and 16α,17-[(1RS)-butylidenebis(oxy)]-21-hydroxy-pregna-1,4-diene-3,11,20-trione(related substance L). The synthetic methods for related substances B, C, and L had not been previously reported in the literature.The chemical structures of these related substances were confirmed by ¹H NMR, ¹³C NMR, and HRMS.

  • Paper
  • Guizhou HAO, Hua ZHENG, Depeng LIU, Benguan YANG, Yunhui YAO, Zhong FENG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.007

    The physicochemical properties and stability differences of semaglutide(1) bulk drug obtained from two different manufacturing processes were systematically evaluated using multi-scale characterization techniques. This study employed SEM, PXRD, TGA/DSC, dynamic vapor sorption analysis, and HPLC to characterize the microcrystal habit, polymorphic structure, thermal properties, hygroscopic behavior, and solubility of the samples, respectively.Influence factor tests were performed to preliminarily investigate their stability. The results showed that the samples prepared by both processes were amorphous and exhibited irregular flake-like crystal habits, with distinct differences in surface topography. Both samples displayed thermodynamic instability, susceptibility to thermal degradation, strong hygroscopicity, and low solubility in acidic media. Under accelerating conditions(high temperature, high humidity,and intense light exposure), the contents of related substances and moisture in both samples showed an increasing trend. In summary, 1bulk drug prepared by the two processes exhibited comparable quality, and both could be used for the development of 1injection and oral tablets. This study can provide data support and theoretical guidance for the screening of 1bulk drug and process selection during formulation development.

  • Paper
  • Naijian ZOU, Lei CHANG, Jun WU, Jiapeng LI, Xianzi ZENG, Yingqiang LU
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.008

    The triphenylphosphine(TPP)-modified nanoliposomes co-loaded with daunorubicin(1) and curcumol(2), named TPP-1/2-Lip, were designed and prepared by a thin-film dispersion-ammonium sulfate hydration method. The formulation was optimized by Box-Behnken design combined with response surface methodology. The particle size, PDI, and ζ potential of the optimized TPP-1/2-Lip were (74.30±2.71)nm, 0.07±0.02, and (0.40±0.17)mV,respectively. And the TPP-1/2-Lip showed good stability at 4 ℃. In vitro cellular assays showed that the synergistic score of the two drugs in the nanoliposomes was 12.99(greater than 10), indicating a significant synergistic effect. Meanwhile, the nanoliposomes could be efficiently taken up by human bladder cancer cells(KU-19-19 cells). By targeting the mitochondria of tumor cells, they induced apoptosis, inhibited cell proliferation and migration, and blocked vasculogenic mimicry,showing superior efficacy to that of the non-targeted nanoliposomes or nanoliposomes with a single drug. In summary,the mitochondrial-targeting and dual-drug synergistic delivery strategy developed in this study provides a novel idea for overcoming chemotherapy resistance and metastasis in bladder cancer.

  • Paper
  • Yansuo YU, Shilin ZHAO, Baoming NING, Qiang LIU, Shuye QI
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.009

    To evaluate the feasibility of an imaging-based approach for determining the disintegration time of orally disintegrating tablets(ODTs), an imaging system integrating an industrial camera, illumination module, and image-processing workflow was developed. Using the Tricorptester as the reference instrument, the in vitro disintegration behaviors of three commercially available ODT formulations(containing ambroxol hydrochloride, domperidone, or loratadine,designated as formulation A to formulation C) were assessed, while the effects of imaging view on the measurement results and the applicability of the method to a special formulation were also investigated. The imaging approach continuously recorded the disintegration process and supported endpoint determination by quantifying residual projected area and mask-pixel changes. For formulations A and B, the imaging approach showed lower variability in the measurement results than the Tricorptester method. Disintegration time values measured from the two imaging views showed no statistically significant differences(P>0.05). For freeze-dried formulation C, for which the Tricorptester only recorded the disintegration time as “≥60 s” without identifying a definite endpoint, the imaging approach was still able to continuously record the disintegration process and identify a definite endpoint. These findings indicate that the imaging approach enables continuous recording and traceable endpoint determination of the disintegration process of ODTs, and provides complementary measurement capability for ultrathin formulations that are difficult to assess using mechanically triggered devices, thus serving as a useful complement to conventional disintegration testing methods.

  • Paper
  • Junling YANG, Liting YU, Yuan ZHAO, Yi LIU, Bo CHENG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.010

    Using the nuclear ribosomal second internal transcribed spacer(ITS2) barcoding technique, molecular identification was performed on the ethnic medicinal plant Clematis songarica Bunge and its easily confused adulterants(Clematis intricata Bunge, Clematis chinensis Osbeck, and Clematis mae Z. Z. Yang & L. Xie). The ITS2 sequences of C. songarica Bunge and its adulterants were amplified and subjected to bidirectional sequencing. Sequencing chromatograms were assembled using CodonCode Aligner 12.0.5 software. Multiple sequence alignment was performed with MEGA 6.0. Subsequently, the intra-and inter-specific genetic distances were calculated, a Neighbor-Joining(NJ) phylogenetic tree was constructed, and the ITS2 secondary structures were predicted. The ITS2 sequence lengths of C. songarica Bunge and its adulterants were 219, 221, 218 and 226 bp, respectively. The similarities between sample ITS2 sequences and the matching reference sequences obtained from GenBank were all no less than 99%. The NJ phylogenetic tree showed that C. songarica Bunge and the above adulterants clustered into independent clades with bootstrap support values greater than 80% for each branch. The intraspecific genetic distance within C. songarica(0.003 7) was significantly smaller than the interspecific genetic distances to its adulterants(0.025 4–0.055 2),forming a clear barcoding gap. Prediction of ITS2 secondary structures revealed obvious differences in the number, size and position of stem-loops within helical regions. The results indicated that, as a DNA barcode, the ITS2 sequence could accurately identify C. songarica Bunge and its adulterants, which provided a reliable technical basis for the authenticity identification and safe application of Clematis medicinal materials.

  • Paper
  • Jiao YIN, Ying WANG, Shantang YANG, Fei LI, Jun HU, Pengliang HAO
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.011

    This study performed environmental monitoring and microbial identification in 23 “controlled not classified”(CNC) areas of a sterile pharmaceutical production workshop from 2024 to 2025. The results indicated significant differences in contamination load and microbial community structure across different functional areas: the changing area had the highest level of contamination with a microbial proportion of 43.75%, followed by the personnel flow area(33.48%), the cleaning area(10.03%), the logistics area(8.92%), and the waste logistics area(3.82%). The microorganisms isolated across all CNC areas were classified into 10 bacterial genera, with Staphylococcus being the most prevalent(32.14%), followed by Bacillus(17.86%), Candida(14.29%), and Micrococcus(10.71%). A baseline database of contaminating microorganisms in CNC areas of the sterile pharmaceutical manufacturing workshop was established,providing data support and scientific evidence for optimizing environmental control, cleaning and disinfection, microbial contamination traceability, and formulating cleanliness standards by pharmaceutical regulatory authorities.

  • Paper
  • Xinyue ZOU, Xiyuchen YANG, Yunong DAI, Xinyi SUN
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.012

    An ICP-MS method was established for the simultaneous determination of 12 types of elemental impurities including cadmium, lead, arsenic, mercury, cobalt, vanadium, nickel, lithium, antimony, molybdenum, copper, chromium in semaglutide bulk drug. The samples were digested by microwave-assisted digestion after addition of nitric acid, and the contents of the 12 elemental impurities in semaglutide bulk drug were simultaneously quantified using the internal standard method. The results showed that each elemental impurity had a good linear relationship between the mass concentration and response signal within its respective range(r>0.999 2), with LODs of 0.000 3 - 0.045 1 μg/g, and LOQs of 0.001 0 -0.136 6 μg/g. The spike recoveries were in the range of 86.3% - 124.6%. The RSDs of repeatability test(n=6) were 0.33% -4.24%. The RSDs of intermediate precision test(n=12) were 0.90% - 6.27%. Three batches of samples were detected by this method, and all elemental impurity levels complied with the specified limits. The method established herein features high sensitivity and acceptable accuracy, and can be applied to the quality control of elemental impurities in semaglutide.

  • Pharmaceutical Management & Information
  • Hui LI, Songyue ZHAO, Qin XU, Hongsheng HAN
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.013
  • Pharmaceutical Management & Information
  • Haibing YIN, Wenjun FU, Jinfang ZHAO, Xiaonan LIU, Yongze WANG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.014
  • Pharmaceutical Management & Information
  • Jiaji WANG, Xing CHENG, Lijia GUI, Wenwu GONG
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.015
  • Pharmaceutical Management & Information
  • Wenxia ZHANG, Xueke MENG, Rui HUANG, Gang FENG, Zhuo LI
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.016
  • Pharmaceutical Management & Information
  • Zhongpeng WANG, Meng REN
    Chinese Journal of Pharmaceuticals. 2026, 57(9): doi: 10.16522/j.cnki.cjph.2026.09.017
News